3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
26
INDUSTRY
4
OTHER_GOV
2
UNKNOWN
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Neoplasm Metastasis
1
Interventions
S 1 (combination)
12
Capecitabine
11
Paclitaxel
9
Cisplatin
9
apatinib
8
Oxaliplatin
8
pyrotinib
6
nimotuzumab
6
130-nm albumin-bound paclitaxel
6
titanium silicide
5
sintilimab
5
camrelizumab
5
anlotinib
5
Etoposide
5
Docetaxel
5
Carboplatin
5
Trastuzumab
4
Radiotherapy, Intensity-Modulated
4
Irinotecan
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
nedaplatin
3
Vinorelbine
3
Temozolomide
3
Tegafur
3
Taxes
3
Radiosurgery
3
Gemcitabine
3
Fluorouracil
3
Epirubicin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
UNKNOWN
×
Platinum Compounds
×
Clear all
NCT05136768
2021-11-29
LM-HNSCC
ChineseAMS
Phase 2
Unknown
50 enrolled